Catheter Precision, Inc. (VTAK)

From the record

Catheter Precision, Inc.'s filings since 2017 show 16 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, 8 times, the latest 2023-08-25); an auditor change (8-K item 4.01, 2 times, the latest 2023-06-26); a late-report notice (Form NT 10-K or NT 10-Q, 6 times, the latest 2026-05-18) (its current reports).

From the record

Catheter Precision, Inc.'s 9 filed years say what it did: revenue went from $6 million in fiscal 2017 to $819 thousand in fiscal 2025, down 21.8% a year; it rose in 4 of 8 years; the deepest fall was 100% from fiscal 2019 to fiscal 2022; net income was positive in 0 of 9 of those years (its annual reports).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Catheter Precision, Inc. lost about 244 cents for every dollar of shareholders' money, and gross profitability: its products earned about 5 cents per dollar of everything the company owns. Leverage: it owed about 56 cents per dollar of assets, and net share issuance: its share count grew 529.1% over the year (the filed statements).

From the record

Catheter Precision, Inc.'s standing among 109 graded names in its industry family: revenue of $819 thousand in fiscal 2025 ranks in the bottom 10% by size; a net margin of -2098% ranks in the bottom 7%; revenue growth of 288.1% a year over the last 3 filed years ranks in the top 1% (its annual reports).

From the record

Catheter Precision, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Jenkins, David A (Chairman of the Board and CEO, as filed), filing under that title since 2025-12-08, 11 months (bottom 19% of its family); the 5 officers and directors filing in the last fifteen months have been on the record a median of 3.8 years (bottom 22%); 8 officer or director changes were reported on Form 8-K since 2023-11-13, against the 5 people in charge now (bottom 6%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Catheter Precision, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $88 thousand against debt of $3 million leaves -18.9% of its assets as net cash, bottom 18% of its family; cash from operations less capital spending is -1015% of revenue (bottom 6%); a gross margin of 92.3% (top 3%); research spending of 105.3% of revenue (top 15%) (its annual report).

From the record

Catheter Precision, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 288.1% a year over the last three filed years against -21.8% over all 9, speeding up (top 1% of its family); the newest year grew 95.1% (top 9%); research spending grew 217.2% a year (top 1%); capital spending grew 0% a year (top 48%) (its annual reports). Catheter Precision, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

Catheter Precision, Inc.'s newest year against its own record: revenue of $819 thousand in fiscal 2025 came in 64.4% below the $2 million its prior three years' pace pointed to (bottom 4% of its family); net income of $17 million against a prior three-year average of $38 million (top 32%); a net margin of a loss larger than its revenue against losses larger than its revenue before (top 1%) (its annual reports).